THC vs CBD vs CBG vs CBN vs THCV: The Real Differences Explained
THC vs CBD vs CBG vs CBN vs THCV explains how each cannabinoid targets different receptors and produces distinct clinical effects. Dr. Benjamin Caplan breaks down the evidence behind pain, sleep, focus, and metabolic use cases for each compound. This…
Oral Cannabigerol (CBG): What a New Human Safety Study Actually Found
Cannabigerol CBG safety study: a controlled human trial in 12 healthy adults found oral CBG well tolerated up to 200 mg, with no drug-related adverse events, minimal psychoactive effects, and normal liver function tests throughout. It keeps the evidence…
Why CBG Topicals Are Becoming One of Hemp’s Fastest-Growing Categories | High Times
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
The Cannabis Component CBG Shows Promise In Treating Rheumatoid Arthritis With Its …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Study: Minor Cannabinoids Show Distinct Effects on Pain-Sensing Neurons
Minor cannabinoids pain management research highlights their distinct effects on pain-sensing neurons. These compounds may offer new therapeutic options beyond THC and CBD. Understanding their role is crucial for advancing cannabinoid therapies.
New Research Highlights Cannabinoids and Fatty Liver Disease
Emerging cannabinoids fatty liver clinical relevance is gaining attention in recent studies. CBD and CBG show promise in improving fatty liver disease outcomes. Clinicians should monitor this evolving evidence carefully.
CED Digest: 35 Items — April 09, 2026
Alabama medical cannabis sales are gearing up for a spring 2026 launch, impacting clinical recommendations. Cannabis compounds CBD and CBG show promise for fatty liver disease treatment. Regulatory enforcement challenges in cannabis beverages also affect…
New Study Highlights Potential of Non-Intoxicating Cannabis Compounds CBD and CBG
This article reviews a new study on non-intoxicating cannabis compounds, focusing on CBD and CBG. The research highlights clinical relevance but lacks full methodological details. Clinicians should await peer-reviewed evidence before applying findings.
Two compounds found in surprising substance reverse liver disease damage, study suggests
This study highlights hepatoprotective effects cannabinoids may have in liver disease models. Early preclinical evidence suggests cannabinoids like CBD and CBG could reduce liver inflammation and improve metabolism. These hepatoprotective effects…
CBG vs CBD: 7 Essential Differences You Need to Know – Social Cannabis
This minor cannabinoids therapeutic potential review highlights key differences between CBG and CBD. Understanding these compounds helps clinicians guide patients effectively. Evidence-based patient education is essential for safe cannabis use.